Trillium Therapeutics Inc (NASDAQ:TRIL)

9.60
Delayed Data
As of May 07
 +0.31 / +3.34%
Today’s Change
5.20
Today|||52-Week Range
20.96
-34.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization357.8K3.2M3.6M2.4M
 
 
 
 
 
 
Operating ExpensesGross Income-357.8K-3.2M-3.6M-2.4M
 
 
 
 
 
General Expenses16.7M22.2M28.9M32.2M
 
 
 
 
 
Research And Development14.2M19.3M26.0M29.4M
 
 
 
 
 
Total Operating Expenses17.0M25.4M32.6M34.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.0M-25.4M-32.6M-34.6M
 
 
 
 
 
Extraordinary Credit0.000.00892.1K520.0K
 
 
 
Extraordinary Charge0.00-238.6K0.00-2.3M
 
 
 
Interest Expense On Debt66.4K62.2K52.4K33.2K
 
 
 
 
 
Other Expenses4.8M-1.5M-3.7M2.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.9M-26.9M-34.8M-32.9M
 
 
 
 
 
Income Taxes-425.4K-3.0M-94.8K-145.8K
 
 
 
 
 
Net Income-11.5M-24.0M-34.7M-32.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.6M7.8M9.8M13.9M
 
 
 
 
 
Shares To Calculate EPS Diluted6.6M7.8M9.8M13.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.74-$3.06-$3.55-$2.36
 
 
 
 
 
EPS Diluted-$1.74-$3.06-$3.55-$2.36